Emmanuel is a principal in ZS’s value and access practice, which provides consulting and research on value, market access and pricing, and health economics and outcomes research. Clients value him highly as a strategic partner with broad expertise across healthcare issues and geographies.
During his 10-plus years at ZS, Emmanuel has advised many large pharmaceutical companies as well as small biotech companies in the U.S., Canada, EU, Africa and Asia on sales and marketing strategy and implementation. Emmanuel’s key therapy areas of expertise include oncology, hemophilia, vaccines, rare diseases and immunology.
Prior to joining the New York office in 2013, Emmanuel spent three years in ZS’s London and Paris offices working primarily on projects in the EU and Northern Africa.
Emmanuel holds a master’s of science in finance and a master’s in management focused on strategy, marketing, finance and accounting from EDHEC Business School. Emmanuel speaks English, French, Italian and Spanish.